S&P 500 Industrials Sector SEC Filings — February 03, 2026

04-02-2026

Alphabet Inc. filed an 8-K on February 4, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a standard earnings-related disclosure, but no specific revenue, earnings, margins, guidance, or other financial metrics are disclosed in the provided filing details. No positive or negative performance indicators, period-over-period changes, or transaction values were mentioned.

• ·Accession Number: 0001652044-26-000012
• ·File Size: 752 KB

04-02-2026

04-02-2026

Stanley Black & Decker, Inc. filed an 8-K on February 4, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed quantitative data available.

04-02-2026

Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on February 4, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other event, transaction values, financial impacts, or exhibits are disclosed in the provided filing summary.

04-02-2026

Midland States Bancorp, Inc. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons, or financial impacts are disclosed.

04-02-2026

Valuence Merger Corp. I filed an 8-K on February 4, 2026 (AccNo: 0001493152-26-004997) under Item 8.01 Other Events announcing a Merger/Acquisition event. No specific deal structure, parties involved, valuation, financial terms, or strategic rationale are disclosed. Sector is not specified.

04-02-2026

Bunge Global SA filed an 8-K on February 4, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing details. This is an informational disclosure of financial results with no directional performance indicators available.

04-02-2026

GE HealthCare Technologies Inc. filed a Form 8-K on 2026-02-04 under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, balance sheet changes, guidance, or other quantitative metrics are disclosed in the provided information. This represents a standard voluntary earnings-related disclosure with no period-over-period comparisons or directional performance indicators available.

• ·AccNo: 0001932393-26-000006
• ·Filing size: 1 MB
• ·Event Type: Financial Results
• ·Sector: not specified

04-02-2026

Avery Dennison Corp filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are mentioned. All quantitative financial metrics and performance details are NOT_DISCLOSED.

04-02-2026

Wabash National Corp filed an 8-K on 2026-02-04 under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information. No positive or negative performance details are available.

04-02-2026

Johnson Controls International plc filed an 8-K on February 4, 2026, under Item 2.02 reporting results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, guidance, or period-over-period metrics are disclosed in the filing summary provided. Critical financial details are likely in attached exhibits but not extracted here.

04-02-2026

IDEX Corp (/DE/) filed an 8-K on February 4, 2026, reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed metrics available.

04-02-2026

Medalist Diversified REIT, Inc. filed an 8-K on February 4, 2026 (AccNo: 0001104659-26-010034), reporting entry into a material definitive agreement under Item 1.01, with exhibits attached under Item 9.01. No specific details on the agreement terms, parties, transaction value, financial impacts, or strategic rationale are disclosed in the provided filing summary. This is a multi-item mandatory disclosure of a material event.

04-02-2026

Matthews International Corp filed an 8-K on February 4, 2026 (AccNo: 0000063296-26-000011), disclosing Results of Operations and Financial Condition under Item 2.02, Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing for financial results, but specific revenue, earnings, guidance, or other metrics are NOT_DISCLOSED. No positive or negative performance details, comparisons, or directional indicators are provided in the filing summary.

04-02-2026

Brookfield Asset Management Ltd. filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02 and departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02. Financial statements and exhibits are referenced under Item 9.01. No specific details on leadership changes, financial metrics, names, positions, reasons, or quantitative data are disclosed in the provided filing information.

04-02-2026

Phillips 66 filed an 8-K on 2026-02-04 disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. This represents a standard financial results announcement for the company. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information.

04-02-2026

Eagle Bancorp Montana, Inc. filed an 8-K on February 4, 2026, reporting under Item 7.01 Regulation FD Disclosure, which is a voluntary disclosure to ensure broad dissemination of material information. Item 9.01 indicates financial statements and exhibits are attached, but no specific details, metrics, transactions, or events are disclosed in the filing summary. No quantitative financial impacts, guidance changes, or scheduled events are mentioned.

04-02-2026

First Northwest Bancorp filed a Form 8-K on February 4, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details on the core event, financial metrics, transactions, or exhibits are disclosed in the provided filing summary. This appears to be a voluntary disclosure with attached materials, but content is NOT_DISCLOSED.

04-02-2026

GBank Financial Holdings Inc. filed an 8-K on February 4, 2026, under Item 7.01 for Regulation FD Disclosure, indicating a voluntary public release of material nonpublic information. Item 9.01 lists Financial Statements and Exhibits, but specific details, metrics, or content are NOT_DISCLOSED. No financial impacts, transactions, or performance data are provided in the filing summary.

04-02-2026

NB Bancorp, Inc. filed a Form 8-K on February 4, 2026 (AccNo: 0001104659-26-010122, size 7 MB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or contents of the exhibits are disclosed. This is a multi-item informational filing with no financial metrics, transactions, or performance data provided.

04-02-2026

MAGELLAN COPPER & GOLD Corp filed a Form 8-K on February 4, 2026 (AccNo: 0001683168-26-000744, Size: 195 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the 'Other Event', transaction values, financial metrics, or exhibits are disclosed in the provided filing summary. This appears to be a multi-item, likely voluntary disclosure with no quantified impacts mentioned.

04-02-2026

Landmark Bancorp Inc filed an 8-K on February 4, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details regarding the core event, financial metrics, transactions, or performance changes (positive, negative, or flat) are disclosed in the provided filing summary. This filing ensures compliance with Regulation FD for sharing material information.

04-02-2026

Hewlett Packard Enterprise Co filed an 8-K on February 4, 2026 (AccNo: 0001645590-26-000006, Size: 180 KB), reporting solely under Item 7.01 Regulation FD Disclosure. No financial metrics, transactions, quantitative data, period-over-period comparisons, or other details are explicitly stated in the provided filing information. This is an informational disclosure with no positive or negative metrics disclosed.

04-02-2026

AMERICAN SUPERCONDUCTOR CORP /DE/ filed an 8-K on February 4, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure typical for earnings announcements, but specific revenue, earnings, guidance, or other financial metrics are NOT_DISCLOSED. No positive or negative performance indicators, period-over-period comparisons, or balance sheet effects are provided in the filing summary.

04-02-2026

U S PHYSICAL THERAPY INC /NV filed a Form 8-K on February 4, 2026 (AccNo: 0000885978-26-000006, Size: 809 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific other events, financial statements, exhibits, transactions, metrics, or impacts are disclosed in the provided filing information. All quantitative and qualitative event specifics are NOT_DISCLOSED.

04-02-2026

Boot Barn Holdings, Inc. filed a Form 8-K on February 4, 2026 (AccNo: 0001104659-26-010309), reporting results of operations and financial condition under Item 2.02, Regulation FD Disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item voluntary disclosure typical for earnings releases, but no specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. No positive or negative performance indicators, period-over-period comparisons, or operational details are available.

04-02-2026

Global AI, Inc. filed an 8-K on February 04, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative impacts are disclosed.

04-02-2026

Lifevantage Corp filed an 8-K on 2026-02-04 disclosing results of operations and financial condition (Item 2.02), a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements (Item 5.02), and financial statements and exhibits (Item 9.01). No specific details on the officer change, including key position, appointment or resignation status, reasons, timing, or any financial metrics are explicitly stated. No quantitative data, period-over-period comparisons, or scheduled events were disclosed.

04-02-2026

TTM Technologies Inc filed an 8-K on February 4, 2026, under Item 2.02 announcing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. All quantitative financial metrics are NOT_DISCLOSED.

04-02-2026

PagerDuty, Inc. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. Specific details on the affected position, individual name, appointment or resignation, reasons, or timing are NOT_DISCLOSED.

04-02-2026

QUALCOMM INC/DE filed a Form 8-K on February 4, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a standard earnings-related disclosure without quantified performance metrics.

04-02-2026

Lipella Pharmaceuticals Inc. filed an 8-K on February 4, 2026 (AccNo: 0001753926-26-000265), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the affected position (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, named individuals, or any quantitative data such as compensation amounts are disclosed. Sector information is NOT_DISCLOSED.

04-02-2026

CENTRAL GARDEN & PET CO filed a Form 8-K on February 4, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item filing typical for earnings announcements. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information.

04-02-2026

BANK OF THE JAMES FINANCIAL GROUP INC filed an 8-K on February 4, 2026, reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard voluntary disclosure of financial results without detailed directional data.

04-02-2026

Bassett Furniture Industries Inc filed a Form 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, or period-over-period comparisons were detailed in the provided filing information. This is a standard earnings-related disclosure with no quantified metrics available.

04-02-2026

NETGEAR, INC. filed an 8-K on February 4, 2026 (AccNo: 0001193125-26-037642), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This constitutes a voluntary disclosure of financial results. No specific revenue, earnings, guidance, or other metrics are disclosed in the provided filing information.

04-02-2026

PVH Corp. /DE/ filed an 8-K on February 4, 2026 (AccNo: 0000078239-26-000005, size 190 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the core event, transaction, financial metrics, or exhibits are disclosed. This appears to be a multi-item filing likely including attached documents such as a press release.

04-02-2026

COPT DEFENSE PROPERTIES filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the officer, position, reason, timing, or any quantitative data are disclosed.

04-02-2026

Launchpad Cadenza Acquisition Corp I filed an 8-K on 2026-02-04 disclosing a merger/acquisition event under Item 8.01 (Other Events) and providing financial statements and exhibits under Item 9.01. No quantitative metrics, deal terms, financial impacts, positive or negative performance indicators, or period-over-period comparisons are disclosed in the provided filing summary. Critical details such as parties involved, valuation, structure, and strategic rationale remain NOT_DISCLOSED.

04-02-2026

GenFlat Holdings, Inc. filed an 8-K on February 4, 2026, disclosing under Item 1.01 entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction size, financial impacts, or other metrics are provided in the available information. This is a multi-item filing with no quantitative data or performance metrics disclosed.

04-02-2026

Murphy USA Inc. filed a Form 8-K on February 4, 2026 (AccNo: 0001573516-26-000026), under Item 2.02 disclosing results of operations and financial condition, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics are provided in the filing summary. This is a standard earnings-related disclosure with no detailed performance data available.

04-02-2026

IF Bancorp, Inc. filed a Form 8-K on February 04, 2026, reporting under Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on voting outcomes, events, financial statements, or exhibits are disclosed. No quantitative metrics, transactions, or performance data provided.

04-02-2026

Adial Pharmaceuticals, Inc. filed an 8-K on February 4, 2026, reporting under Item 3.03 material modifications to rights of security holders, under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details, transaction values, financial metrics, positive or negative changes, or period-over-period comparisons disclosed. No quantitative impacts or directional biases are evident from the available information.

04-02-2026

Standex International Corp/DE/ filed an 8-K on February 4, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits). This is a standard disclosure of financial results with attached exhibits. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative metrics are disclosed in the provided filing information.

04-02-2026

Grayscale CoinDesk Crypto 5 ETF filed a Form 8-K on February 4, 2026 (AccNo: 0001193125-26-037738, Size: 162 KB) under Item 8.01 reporting Other Events. No specific details on the nature of the event, transaction values, financial metrics, positive or negative impacts, or comparisons are disclosed. Sector is not specified.

04-02-2026

Regional Management Corp. filed a Form 8-K on 2026-02-04 reporting results of operations and financial condition under Item 2.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or other quantitative financial metrics are explicitly stated in the provided filing information. This is a multi-item filing typical for earnings announcements, but lacks detailed performance data for analysis.

04-02-2026

Phibro Animal Health Corp filed an 8-K on February 04, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard disclosure for financial results without detailed performance data.

04-02-2026

Kimball Electronics, Inc. filed a Form 8-K on February 4, 2026 (AccNo: 0001606757-26-000006), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics are mentioned in the provided filing description. This appears to be a standard voluntary earnings release without detailed performance data available.

04-02-2026

Core Laboratories Inc. filed an 8-K on February 4, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. This is a multi-item voluntary disclosure typical for earnings releases. No specific revenue, earnings, or other financial metrics are disclosed.

04-02-2026

National Bank Holdings Corp filed an 8-K on February 04, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details regarding the content of the Regulation FD disclosure or the attached exhibits are disclosed in the provided filing information.

04-02-2026

Orange County Bancorp, Inc. filed an 8-K on February 4, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), indicating a voluntary disclosure of financial results. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative metrics are disclosed in the provided filing details. This is purely informational without directional financial data.

04-02-2026

Laser Photonics Corp filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the key position affected, appointment or resignation status, reasons for change, and any governance implications are NOT_DISCLOSED.

04-02-2026

GEOSPACE TECHNOLOGIES CORP filed an 8-K on February 4, 2026, under Item 2.02 announcing results of operations and financial condition, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing details. This appears to be a standard voluntary earnings release filing.

04-02-2026

Luminar Technologies, Inc./DE filed an 8-K on February 4, 2026, disclosing the termination of a material definitive agreement under Item 1.02 and the completion of an acquisition or disposition of assets under Item 2.01. Item 9.01 references financial statements and exhibits, but no specific financial metrics, parties, or terms were detailed. This filing provides informational updates on transactional events without quantified impacts.

04-02-2026

GE Vernova Inc. filed a Form 8-K on February 4, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the exhibits are disclosed. No financial metrics, transactions, or performance data are mentioned, resulting in no identifiable positive or negative impacts.

04-02-2026

Cumberland Pharmaceuticals Inc filed a Form 8-K on February 4, 2026 (AccNo: 0001087294-26-000011, Size: 180 KB), reporting solely under Item 8.01 Other Events. The core nature of the other event is NOT_DISCLOSED, with no financial metrics, quantitative data, period-over-period comparisons, or operational details provided. No positive, negative, or flat performance indicators are mentioned.